๐Ÿ”ฌDeep Research

ADPT โ€” Adaptive Biotechnologies Corp ยท catalysts, narrative & risks

ยท22 sourcesADPT forecast โ†’

Adaptive Biotechnologies Corp. (ADPT) โ€” as of ~October 3, 2026

Below is a synthesis of the new sources, drawn on critically and cross-checked against each other. Note where aggregators conflict.

Market snapshot

ADPT closed at roughly $28.35 on October 2, 2026, with a market capitalization near $4.52 billion, ~159.6M shares outstanding, and a beta near 2.1 [11][20][22]. The stock is near its 52-week high of ~$29.96 (and has roughly doubled the market cap year-over-year, +104%) [14][20][24]. It is classified under Healthcare / Diagnostics & Research [22].


AI-assisted research from the K3vl4r desk โ€” not personalized investment advice. More research โ†’